+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
ID07562932

Comparing Norepinephrine and Dopamine as First-Line Treatments for Cardiogenic Shock in Adults

Led by Chonnam National University Hospital · Updated on 2026-10-15

512

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare norepinephrine and dopamine as the first vasoactive drugs for treating cardiogenic shock in adults. Cardiogenic shock is a serious condition where the heart cannot pump enough blood, leading to tissue damage and high risk of death. The study evaluates which drug better stabilizes blood pressure, improves tissue perfusion, and prevents worsening shock during early treatment. Participants will be randomly assigned to receive either norepinephrine or dopamine through continuous intravenous infusion, following a specific dosing plan that adjusts based on their response and clinical condition. Both drugs are administered using infusion pumps in intensive care units, with treatment and monitoring following current clinical guidelines. The infusion duration depends on each participants stabilization. During the study, participants will undergo regular monitoring of blood pressure, heart rhythm, laboratory tests, and organ function while hospitalized. Researchers will follow participants for outcomes at 1 month, 6 months, and 1 year after enrollment. The main measure is a combination of death or worsening shock within 28 days. Additional outcomes include complications like arrhythmias, mechanical support needs, and rehospitalization. Safety and effectiveness will be assessed throughout the study period.

CONDITIONS

Brief Title

Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock

Research Team

M

Min Chul Kim, Professor, MD, PhD

Y

Yongwhan Lim, Professor, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here